ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

GTHX G1 Therapeutics Inc

4,1899
-0,0801 (-1,88%)
Zuletzt aktualisiert: 19:14:24
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
G1 Therapeutics Inc GTHX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,0801 -1,88% 4,1899 19:14:24
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,27 4,1201 4,28 4,27
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202423:50GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
01.5.202412:30GLOBEG1 Therapeutics Provides First Quarter 2024 Financial..
01.5.202412:25GLOBEG1 Therapeutics and Pepper Bio Announce Global (Excluding..
17.4.202415:00GLOBEG1 Therapeutics to Release First Quarter 2024 Financial..
04.4.202416:30GLOBEG1 Therapeutics to Participate in the 23rd Annual Needham..
01.4.202422:20GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
01.3.202422:20GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
28.2.202412:35EDGAR2Form 8-K - Current report
28.2.202412:30GLOBEG1 Therapeutics Provides Fourth Quarter and Full Year 2023..
27.2.202414:30GLOBEG1 Therapeutics to Participate in the TD Cowen 44th Annual..
15.2.202414:30GLOBEG1 Therapeutics to Release Fourth Quarter and Full Year 2023..
14.2.202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:42EDGAR2Form 144 - Report of proposed sale of securities
12.2.202422:19EDGAR2Form 8-K - Current report
12.2.202422:05GLOBEG1 Therapeutics to Continue Pivotal Phase 3 Trial of..
09.1.202422:19EDGAR2Form 144 - Report of proposed sale of securities
08.1.202412:45GLOBEG1 Therapeutics Provides Corporate Update at the 42nd Annual..
08.1.202412:30EDGAR2Form 8-K - Current report
08.1.202412:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202412:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202412:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202412:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202412:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202412:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202415:00GLOBEG1 Therapeutics to Participate in the 42nd Annual J.P...
03.1.202401:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202422:51GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
13.12.202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202322:40EDGAR2Form 144 - Report of proposed sale of securities
12.12.202300:43EDGAR2Form 144 - Report of proposed sale of securities
05.12.202315:26GLOBEG1 Therapeutics Presents New Post Hoc Analyses Indicating..
01.12.202322:27GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
30.11.202302:37GLOBEG1 Therapeutics Announces Upcoming Presentation at the 2023..
01.11.202321:37EDGAR2Form S-8 - Securities to be offered to employees in employee..
01.11.202321:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01.11.202311:46EDGAR2Form 8-K - Current report
01.11.202311:30GLOBEG1 Therapeutics Provides Third Quarter 2023 Financial..
27.10.202313:00GLOBEReal World Data Indicate That Trilaciclib Reduces..
18.10.202314:00GLOBEG1 Therapeutics’ COSELA® (trilaciclib) Recommended in..
18.10.202313:30GLOBEG1 Therapeutics to Release Third Quarter 2023 Financial..
16.10.202315:00GLOBEG1 Therapeutics Announces Upcoming Presentations at the 2023..
21.9.202322:15EDGAR2Form 8-K - Current report
18.9.202313:00GLOBEBlack Diamond Therapeutics Announces CEO Transition
05.9.202317:00GLOBEG1 Therapeutics to Participate in the H.C. Wainwright 25th..
01.9.202322:15GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
10.8.202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.8.202301:28EDGAR2Form 144 - Report of proposed sale of securities
02.8.202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.8.202312:50EDGAR2Form 8-K - Current report
02.8.202312:30GLOBEG1 Therapeutics Provides Second Quarter 2023 Financial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock